FLEX REPORTS FIRST QUARTER FISCAL 2027 RESULTS

CapsoVision anticipates FDA clearance for AI Highlights by end of Q3 as it targets Q4 CapsoCam Colon submission

Smith Micro expects Q3 2026 revenue of $5.0M-$5.4M as SafePath launches move into Q3

TSS maintains full-year adjusted EBITDA outlook toward upper end of $20M-$22M range as $17M Vera Rubin buildout nears September completion

Genasys signals fiscal 2026 record year outlook as it expects to complete initial $9M CROWS delivery within the year